GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Total Long-Term Assets

TheraCryf (FRA:8EV) Total Long-Term Assets : €1.31 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. TheraCryf's Total Long-Term Assets for the quarter that ended in Sep. 2024 was €1.31 Mil.

TheraCryf Total Long-Term Assets Historical Data

The historical data trend for TheraCryf's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Total Long-Term Assets Chart

TheraCryf Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.08 0.07 0.05 0.04

TheraCryf Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.05 0.04 1.31

TheraCryf Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

TheraCryf Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of TheraCryf's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Total Long-Term Assets
Comparable Companies
LSE:GENF LSE:APTA LSE:BSFA LSE:CIZ LSE:CRTX LSE:ROQ AQSE:INC LSE:FAB LSE:NFX LSE:HEMO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
TCF:UK
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
Website
https://www.evgen.com
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.

TheraCryf Headlines

No Headlines